Results 1 to 10 of about 443,239 (291)
Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]
, 2017 OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M +16 more
core +18 more sources
Journal of Cardiovascular Development and Disease, 2023 (1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-
Artem Ovchinnikov +6 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Aims: Evidence-based guidelines for heart failure management depend mainly on current left ventricular ejection fraction (LVEF). However, fewer studies have examined the impact of prior LVEF.
Xinxin Zhang +9 more
doaj +1 more source
ESC Heart Failure, 2023 Aims This study aimed to determine the impact of heart failure (HF) on clinical outcomes in patients with atrial fibrillation (AF). Methods and results We analysed data from Polish participants of the EURObservational Research Programme‐AF General Long ...
Monika Budnik +13 more
doaj +1 more source
ESC Heart Failure, 2023 Aims This study aimed to investigate the prognostic value of dynamic changes in left ventricular ejection fraction (EF) for cardiovascular (CV) outcomes in an all‐comer heart failure (HF) population with reduced EF (HFrEF, EF 4 vs.
Dan Liu +7 more
doaj +1 more source
Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang +5 more
doaj +1 more source
ESC Heart Failure, 2022 Aims Heart failure with mildly reduced ejection fraction (HFmrEF) is associated with a favourable prognosis compared with heart failure (HF) with reduced ejection fraction (EF). We assessed whether left ventricular ejection fraction (LVEF) trajectory can
Robert J.H. Miller +8 more
doaj +1 more source
Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment [PDF]
Reviews in Cardiovascular Medicine, 2022 Heart failure (HF) is a complex clinical syndrome resulting from the impairment of ventricular filling or ejection of blood or both, leading to considerable morbidity and mortality. Based on left ventricular ejection fraction (LVEF), the 2016 European
Zhi Shang, Xinyu Wang, Wei Gao
doaj +1 more source
The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
Cardiac Failure Review, 2022 Heart failure (HF) is a major health burden associated with significant morbidity and mortality. Approximately half of all HF patients have reduced ejection fraction (left ventricular ejection fraction
Rebecca C Gosling, Abdallah Al-Mohammad
doaj +1 more source